Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study.

Jay S Wunder1, Nalan Gokgoz, Robert Parkes

  • 1Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5. wunder@mshri.on.ca

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|March 1, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of Patients With Femoroacetabular Impingement Syndrome Using a Pelvic Tilt-Focused Exercise Program: A Prospective Cohort.

The American journal of sports medicine·2026
Same author

Trajectories of disability and influence of contextual factors among adults aging with HIV: Insights from a community-based longitudinal study in Toronto, Canada.

PloS one·2025
Same author

Reassessing the minimal clinically important differences of patient-reported outcomes in cervical myelopathy: a patient-centered approach from the Canadian Spine Outcomes and Research Network.

Journal of neurosurgery. Spine·2025
Same author

Item Reduction and Scoring of the Pediatric PainSCAN ©: A Screening Tool for Pediatric Neuropathic Pain and Complex Regional Pain Syndrome.

The Clinical journal of pain·2025
Same author

The construct validity and responsiveness of measures of the predictability of intermittent knee pain in knee osteoarthritis.

Osteoarthritis and cartilage open·2025
Same author

Reliability and validity of the Pediatric PainSCAN: a screening tool for pediatric neuropathic pain and complex regional pain syndrome.

Pain·2025
This summary is machine-generated.

TP53 gene mutations do not predict metastasis in extremity osteosarcoma. Large tumor size and poor response to chemotherapy are key predictors of systemic relapse in these patients.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • TP53 gene mutations are linked to chemotherapy resistance and poor prognosis in various cancers.
  • Understanding genetic factors influencing osteosarcoma progression is crucial for improving patient outcomes.

Purpose of the Study:

  • To prospectively evaluate the prognostic value of somatic TP53 mutations in newly diagnosed extremity osteosarcoma.
  • To determine if TP53 gene status predicts systemic recurrence in osteosarcoma patients.

Main Methods:

  • 196 patients with high-grade, nonmetastatic extremity osteosarcoma were prospectively studied.
  • TP53 mutations were analyzed using polymerase chain reaction and DNA sequencing.
  • Survival analyses assessed the association between TP53 status and systemic recurrence risk.

Related Experiment Videos

Main Results:

  • No significant association was found between TP53 gene status and systemic relapse (RR 1.24, P = .41).
  • Large tumor size (>9 cm) and poor histologic response to chemotherapy (≤90% necrosis) were independent predictors of systemic outcome.
  • Patient age was the only factor associated with TP53 gene status (P = .05).

Conclusions:

  • TP53 mutations do not appear to predict metastasis development in high-grade osteosarcoma.
  • Further research is needed to identify other genes influencing chemotherapy response and clinical outcomes in osteosarcoma.